An expeditious synthesis of the MDM2-p53 inhibitor AM-8553

Brian S Lucas1, Benjamin Fisher, Lawrence R McGee

  • 1Department of Medicinal Chemistry, Amgen, Inc., S. San Francisco, California 94080, United States. blucas@amgen.com